Breaking

RRG Alert Tech Vaults to ‘Leading’—Is XLK Signaling a New Rally?
Israel has threatened to kill Iran’s supreme leader. Here’s what could come next
The US can end Iran conflict with one call, official from Iran’s presidency says
Trump’s two-week delay on Iran strike decision leaves Israel in limbo
Last BTS member Suga discharged from South Korean military service, paving way for reunion
Armed rebels take control of Heineken facilities in DR Congo’s war-hit east
Apple looking to make ‘premium’-priced folding iPhones starting next year, analyst says
Oil prices rise more than 1% as Israel vows to intensify attacks on Iran

Investing
Economy
Latest News
Stock
Search for:

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Crypto Market Recap: Bitcoin Price Stalls as Fed Holds Rates Steady, Circle Shares Jump

Ericsson, Rogers Launch Canada’s First Underground 5G Network for Smart Mining

Jeffrey Christian: Gold, Silver, PGMs — Short-term Prices and Key Drivers

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Please enter CoinGecko Free Api Key to get this plugin works.

Disclaimer: BigCapitalTrend.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2025 bigcapitaltrend.com | All Rights Reserved

Top

Investing
Economy
Latest News
Stock

Type above and press Enter to search. Press Esc to cancel.